Obsessive-compulsive disorder in adulthood: Etiology, diagnosis, and treatment

Обсессивно-компульсивное расстройство во взрослом возрасте: этиология, диагностика и лечение
Ulrich Voderholzer, Hans Jörgen Grabe, Lena Jelinek, Dominique Endres, Rebecca Schennach, Katharina Domschke
2026-10-06

Cognitive behavioral therapyDeep brain stimulationExposure and response preventionObsessive-compulsive disorderSelective serotonin reuptake inhibitors
BACKGROUND: Obsessive-compulsive disorder (OCD) is common, with a lifetime prevalence of 1.3-4.1%, and it usually markedly impairs the quality of life of those affected. The rationale behind this article is to present an up-to-date review of the etiology, diagnosis, and treatment recommendations of OCD in adults. METHODS: This narrative review is based on relevant publications, including the revised German clinical practice guideline on OCD. RESULTS: Genetic factors are estimated to account for 50% of the variance in OCD; up to 30 independent associated loci have been identified across the genome. Stressful and emotionally traumatic life events are psychological risk factors. OCD is characterized by obsessions and compulsions. The ICD-11 subclassifies OCD by the patient's degree of insight into the disorder ranging from "fair to good" to "poor to absent" insight. It also classifies OCD together with related disorders including body dysmorphic disorder, olfactory reference disorder, hypochondriasis, pathological hoarding, body-focused repetitive behaviors, and Tourette syndrome. Disorder-specific cognitive behavioral therapy, with exposure and response prevention, is the first line of treatment with high effect sizes (Hedges' g: 1.13-1.39). Pharmacological therapy primarily involves serotonergic antidepressants (SSRI as first-line and clomipramine as second-line treatment). If necessary, treatment may be augmented with low-dose atypical antipsychotic drugs (aripiprazole or risperidone). For non-responders to psychotherapy and psychopharmacotherapy repetitive transcranial magnetic stimulation or bilateral deep brain stimulation may be considered. Novel treatment approaches and formats are now being clinically studied, including Bergen four-day treatment, Internet-based and virtual therapies, and glutamatergic agents. CONCLUSION: Effective evidence-based treatments for OCD are already available, and promising new approaches are being studied. A major challenge remains in making these disorder-specific treatments available to patients with OCD.
1
Disorder-specific cognitive behavioral therapy with exposure and response prevention is first-line treatment, showing high effect sizes (Hedges’ g: 1.13–1.39).
2
Evidence-based treatments are available, but ensuring access to disorder-specific care remains a major challenge.
3
Genetic factors explain an estimated 50% of OCD variance, with up to 30 independent associated genomic loci identified; stressful or traumatic events are psychological risk factors.
4
ICD-11 classifies OCD by insight level and groups it with related disorders including body dysmorphic disorder, hoarding disorder, and Tourette syndrome.
5
OCD has a lifetime prevalence of 1.3–4.1% and substantially impairs affected individuals’ quality of life.
6
SSRIs are first-line pharmacotherapy and clomipramine second-line; augmentation, neuromodulation, and emerging internet-based, intensive, virtual, or glutamatergic treatments may benefit non-responders.

Obsessive-compulsive disorder (OCD) in adults

The etiology, clinical characteristics, diagnosis, evidence-based treatment, and emerging therapeutic approaches for adult OCD

Publication Details
Publication Date
2026-10-06
Journal
Publisher
ISSN
Cited by
0
Access Type
Author Information
Authors
Ulrich Voderholzer
Hans Jörgen Grabe
Lena Jelinek
Dominique Endres
Rebecca Schennach
Katharina Domschke
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%